Literature DB >> 7945218

Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.

M Kracht1, M Shiroo, C J Marshall, J J Hsuan, J Saklatvala.   

Abstract

We have isolated from KB cells stimulated with interleukin-1 (IL-1) a protein kinase that phosphorylates a peptide (T669) based on the sequence around T669 of the epidermal growth factor (EGF) receptor. The enzyme, which had an apparent molecular mass of 45 kDa on gel-filtration chromatography, was purified 170,000-fold from cytosolic extracts by sequential chromatography on Mono Q, Mono S, phenyl-Sepharose, Superose 12, ATP-Sepharose and Mono Q. The enzyme activity co-chromatographed at the last step with a 45 kDa protein band that stained for phosphotyrosine. This peak fraction also contained some actin and a 60 kDa protein that stained weakly for phosphotyrosine. The T669 peptide is a substrate for mitogen-activated protein (MAP) kinase. Amounts of IL-1-induced T669 kinase and activated recombinant p42 MAP kinase having equal activity on T669 peptide were compared on commonly used MAP kinase substrates. T669 kinase was two or three orders of magnitude less active on myelin basic protein or microtubule-associated protein-2 than was MAP kinase. The IL-1-induced T669 kinase did not react with antiserum to p42/p44 MAP kinase. It was inactivated by treatment with protein phosphatase 2A or protein phosphotyrosine phosphatase 1B, so it may be regulated by dual phosphorylation in similar fashion to MAP kinase. The dephosphorylated enzyme was not re-activated by MAP kinase kinase. This novel enzyme could lie on a kinase cascade induced by IL-1. It may be responsible for phosphorylating T669 of the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945218      PMCID: PMC1137315          DOI: 10.1042/bj3020897

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation.

Authors:  G Draetta
Journal:  Trends Biochem Sci       Date:  1990-10       Impact factor: 13.807

2.  IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.

Authors:  T A Bird; J Saklatvala
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654.

Authors:  T A Bird; J Saklatvala
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

5.  pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine.

Authors:  J M Kyriakis; J Avruch
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells.

Authors:  P Kaur; W J Welch; J Saklatvala
Journal:  FEBS Lett       Date:  1989-12-04       Impact factor: 4.124

7.  Signal transduction pathway for IL-1. Involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase.

Authors:  M Chedid; F Shirakawa; P Naylor; S B Mizel
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

8.  Interleukin 1 and tumour necrosis factor increase phosphorylation of fibroblast proteins.

Authors:  P Kaur; J Saklatvala
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

9.  Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1.

Authors:  D L Charest; G Mordret; K W Harder; F Jirik; S L Pelech
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

Review 10.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

View more
  7 in total

1.  Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.

Authors:  A Finch; W Davis; W G Carter; J Saklatvala
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

3.  Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1.

Authors:  R Zinck; M A Cahill; M Kracht; C Sachsenmaier; R A Hipskind; A Nordheim
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

4.  Specific activation of beta-casein kinase by the inflammatory cytokines interleukin 1 and tumour necrosis factor.

Authors:  F Guesdon; R J Waller; J Saklatvala
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

5.  Cyclic nucleotide binding proteins in the Arabidopsis thaliana and Oryza sativa genomes.

Authors:  Dave Bridges; Marie E Fraser; Greg B G Moorhead
Journal:  BMC Bioinformatics       Date:  2005-01-11       Impact factor: 3.169

6.  Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats.

Authors:  Ali R Alhoshani; Mohamed M Hafez; Sufia Husain; Abdel Malek Al-Sheikh; Moureq R Alotaibi; Salim S Al Rejaie; Musaad A Alshammari; Mashal M Almutairi; Othman A Al-Shabanah
Journal:  BMC Nephrol       Date:  2017-06-15       Impact factor: 2.388

7.  Interleukin 1 alpha activates two forms of p54 alpha mitogen-activated protein kinase in rabbit liver.

Authors:  M Kracht; O Truong; N F Totty; M Shiroo; J Saklatvala
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.